| Datum | Zeit | Quelle | Überschrift | Symbol | Firma |
| 06/05/2015 | 09h28 | Analyst Ratings Network | Sarepta Therapeutics Upgraded to Outperform at Robert W. Baird (AVII) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 12/07/2012 | 14h20 | Marketwired | Booming Biotechnology Industry Continues to Impress Investors in 2012 | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 12/07/2012 | 12h50 | Marketwired | AVI BioPharma Announces Corporate Name Change to Sarepta Therapeutics and Stock Ticker Symbol Change to "SRPT" Effective Today | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 11/07/2012 | 12h04 | Edgar (US Regulatory) | Amended Statement of Ownership (SC 13G/A) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 06/07/2012 | 22h05 | Marketwired | AVI BioPharma to Present Company Overview at the Seventh Annual JMP Securities Healthcare Conference | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 13/06/2012 | 12h03 | Edgar (US Regulatory) | Proxy Statement (definitive) (DEF 14A) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 05/06/2012 | 22h08 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 01/06/2012 | 23h28 | Edgar (US Regulatory) | Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 01/06/2012 | 22h30 | Marketwired | AVI BioPharma Receives NASDAQ Notice of Minimum Bid Price Non-Compliance | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 11/05/2012 | 15h59 | Marketwired | Potential Breakout Stock to Watch for 05/11/12: AVVC Issues News Release | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 10/05/2012 | 22h14 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 10/05/2012 | 22h05 | Marketwired | AVI BioPharma Announces First Quarter 2012 Financial Results and Recent Corporate Developments | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 10/05/2012 | 15h04 | Edgar (US Regulatory) | Quarterly Report (10-Q) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 04/05/2012 | 14h20 | Marketwired | U.S Patent System to Transform From "First to Invent" to "First to File" - AVI BioPharma and XOMA Look to Benefit | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 04/05/2012 | 10h14 | Zacks | Zacks #1 Rank Additions for Friday - Tale of the Tape | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 03/05/2012 | 14h30 | Marketwired | AVI BioPharma Announces First Quarter 2012 Financial Results and Corporate Update Conference Call | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 02/05/2012 | 10h14 | Zacks | Zacks #1 Rank Additions for Wednesday - Tale of the Tape | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 30/04/2012 | 22h34 | Edgar (US Regulatory) | Amended Annual Report (10-K/A) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 25/04/2012 | 23h26 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 25/04/2012 | 23h25 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 25/04/2012 | 23h21 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 25/04/2012 | 23h05 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 25/04/2012 | 14h30 | Marketwired | AVI BioPharma to Present Additional Data From the Phase IIb Study of Eteplirsen for the Treatment of Duchenne Muscular Dystro... | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 20/04/2012 | 16h10 | Edgar (US Regulatory) | Confidential Treatment Order (CT ORDER) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 12/04/2012 | 22h33 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 02/04/2012 | 15h12 | Dow Jones News | US STOCK FUTURES: HOT STOCKS TO WATCH | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 02/04/2012 | 14h07 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 02/04/2012 | 13h00 | Marketwired | AVI BioPharma Announces Eteplirsen Meets Primary Endpoint, Demonstrating a Significant Increase in Dystrophin at 24 Weeks Com... | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 31/03/2012 | 02h00 | Marketwired | AVI BioPharma Announces Conference Call and Webcast on Monday, April 2, 2012, to Discuss Top-Line Data Results From the Phase... | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 30/03/2012 | 14h30 | Marketwired | Data From AVI BioPharma's Infectious Disease Programs to Be Presented at the 22nd European Congress of Clinical Microbiology ... | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |